Patent Assignment
Reel/Frame 048633/0673
Security Interest
Recorded: 2019-03-18
Pages: 15
Assignor
PORTOLA PHARMACEUTICALS, INC.
Executed: 2019-03-18
Assignee
HCR COLLATERAL MANAGEMENT, LLC
300 ATLANTIC STREET, SUITE 600, STAMFORD, CONNECTICUT, 06901
Covered Properties
(84)
Platlet Adp Receptor Inhibitors
Platelet Adp Receptor Inhibitors
Substituted Isoquinolinones
Methods of Treatment with Syk Inhibitors
Substituted 2H-1,3-Benzoxazin-4(3H)-Ones
Platelet Adp Receptor Inhibitors
[4-(6-Halo-7-Substituted-2,4-Dioxo-1,4-Dihydro-2H-Quinazolin-3-Yl)-Phenyl]-5-Chloro-Thiophen-2-Yl-Sulfonylureas and Forms and Methods Related Thereto
Platelet Adp Receptor Inhibitors
Substituted Dihydroquinazolines as Platelet Adp Receptor Inhibitors
Protein Kinase Inhibitors
Antidotes for Factor Xa Inhibitors and Methods of Using the Same
Inhibitors of Protein Kinases
Inhibitors of Syk and Jak Protein Kinases
Inhibitors of Protein Kinases
Platelet Adp Receptor Inhibitors
Antidotes for Factor Xa Inhibitors and Methods of Using the Same in Combination with Blood Coagulating Agents
Antidotes for Factor Xa Inhibitors and Methods of Using the Same
Inhibitors of Jak
Unit Dose Formulation of Antidotes for Factor Xa Inhibitors and Methods of Using the Same
Combination Therapy with a Compound Acting as a Platelet Adp Receptor Inhibitor
Methods of Synthesizing Factor Xa Inhibitors
CRYSTALLINE FORMS OF A FACTOR Xa INHIBITOR
Methods of Treatment with Syk Inhibitors
Inhibitors of Syk and Jak Protein Kinases
Platelet Adp Receptor Inhibitors
Inhibitors of Syk and Jak Protein Kinases
Nicotinamides as Jak Kinase Modulators
Benzamides and Nicotinamides as Syk Modulators
Inhibitors of Protein Kinases
Antidotes for Factor Xa Inhibitors and Methods of Using the Same
Inhibitors of Protein Kinases
Antidotes for Factor Xa Inhibitors and Methods of Using the Same
Inhibitors of Syk and Jak Protein Kinases
Substituted Pyrazine-2-Carboxamide Kinase Inhibitors
Inhibitors of Jak
METHODS OF SYNTHESIZING FACTOR Xa INHIBITORS
Compounds and Methods for Purification of Serine Proteases
1,2,4-Triazine-6-Carboxamide Kinase Inhibitors
Antidotes for Factor Xa Inhibitors and Methods of Using the Same
Antidotes for Factor Xa Inhibitors and Methods of Using the Same
Inhibitors of Protein Kinases
Pharmaceutical Compositions, Dosage Forms and New Forms of the Compound of Formula (I), and Methods of Use Thereof
Antidotes for Factor Xa Inhibitors and Methods of Using the Same
Pyrazine Kinase Inhibitors
Bicyclic Dihydropyridone Kinase Inhibitors
Bicyclic Oxa-Lactam Kinase Inhibitors
Substituted Pyrimidinyl Kinase Inhibitors
Benzamides and Nicotinamides as Syk Modulators
Inhibitors of Protein Kinases
Inhibitors of Syk and Jak Protein Kinases
Compounds and Methods for Purification of Serine Proteases
Antidotes for Factor Xa Inhibitors and Methods of Using the Same
Pyridazine Compounds as Jak Inhibitors
Benzamides and Nicotinamides as Syk Modulators
Antidotes for Factor Xa Inhibitors and Methods of Using the Same
Cerdulatinib for Treating Myeloma
Application:
15/235,972 →
Publication:
US 2017/0042896
Antidotes for Factor Xa Inhibitors and Methods of Using the Same
Prevention and Treatment of Thrombosis in Medically Ill Patients
Application:
15/456,133 →
Publication:
US 2018/0028510
Cerdulatinib for the Treatment of B-Cell Malignancies
Application:
15/578,190 →
Publication:
US 2018/0147203
Preparation of Factor Xa Derivatives
Composition and Methods of Use of Tetrahydroisoquinoline Small Molecules to Bind and Modulate PCSK9 Protein Activity
Composition and Methods of Use of Novel Phenylalanine Small Organic Compounds to Directly Modulate PCSK9 Protein Activity
Phenylpiperazine Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Modulators and Their Use
Cerdulatinib for Treating Hematological Cancers
Lyophilized Formulations for Factor Xa Antidote
Application:
15/820,265 →
Publication:
US 2018/0320160
Inhibitors of Protein Kinases
Unit Dose Formulation of Antidotes for Factor Xa Inhibitors and Methods of Using the Same
MODULATION OF FACTOR Xa INHIBITOR-MEDIATED BLOOD LOSS BY PARTIAL AND TRANSIENT ADMINISTRATION OF ANTIDOTE
Application:
15/902,886 →
Publication:
US 2018/0185459
Inhibition of Tissue Factor Pathway Inhibitor with Factor Xa Derivatives
Application:
15/919,014 →
Publication:
US 2018/0333469
Compounds for Binding Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)
Application:
16/078,578 →
Publication:
US 2019/0119236
Lyophilized Formulations for Factor Xa Antidote
Application:
16/078,596 →
Publication:
US 2019/0046450
Process for Making Recombinant Antidote to Factor Xa Inhibitor
Application:
16/127,864 →
Publication:
US 2019/0127720
Antidotes for Factor Xa Inhibitors and Methods of Using the Same
Prevention and Treatment of Thrombosis in Medically Ill Patients
Application:
16/256,909 →
Publication:
US 2020/0016133
Methods of Use and Pharmaceutical Compositions of a Selective Syk Inhibitor
Application:
62/641,094 →
Methods of Use and Pharmaceutical Compositions of a Selective Syk Inhibitor
Application:
62/663,999 →
Solid Forms of Cerdulatinib
Application:
62/667,226 →
Synthesis of Cerdulatinib
Application:
62/667,235 →
Methods for Treating Lymphoma
Application:
62/667,249 →
Methods for Treating Lymphoma
Application:
62/678,934 →
Methods of Prevention and Treatment of Thrombosis
Application:
62/678,951 →
Antidotes to Factor Xa Inhibitors
Application:
62/686,968 →
Methods for Treating Lymphoma
Application:
62/736,047 →
Methods for Treating Intracranial Hemorrhage and Assessing Efficacy
Application:
62/802,645 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 18, 2005
From: SCARBOROUGH, ROBERT M.; KANE-MAGUIRE, KIM; MARLOWE, CHARLES K.; SMYTH, MARK S.
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 016154/0844 →
Assignment of Assignor's Interest
May 25, 2005
From: ANDRE, PATRICK; PHILIPS, DAVID R.; HOMCY, CHARLES
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 016596/0898 →
Assignment of Assignor's Interest
Dec 15, 2005
From: SCARBOROUGH, ROBERT M.; VENKATRAMAN, MEENAKSHI S.; ZHANG, XIAOMING; PANDEY, ANJALI
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 017362/0718 →
Assignment of Assignor's Interest
Feb 12, 2007
From: SCARBOROUGH, ROBERT; HUANG, WOLIN; MEHROTRA, MUKUND; ZHANG, XIAOMING
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 018881/0953 →
Assignment of Assignor's Interest
Feb 19, 2008
From: SCARBOROUGH, ROBERT M.; BAUER, SHAWN M.; PANDEY, ANJALI
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 020524/0578 →
Assignment of Assignor's Interest
Oct 27, 2008
From: SONG, YONGHONG; XU, QING; PANDEY, ANJALI
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 021740/0401 →
Assignment of Assignor's Interest
Dec 16, 2008
From: LU, GENMIN; PHILLIPS, DAVID R.
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 021989/0989 →
Assignment of Assignor's Interest
Apr 14, 2009
From: LU, GENMIN; PHILLIPS, DAVID R.; ANDRE, PATRICK; SINHA, UMA
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 022546/0431 →
Assignment of Assignor's Interest
Dec 10, 2009
From: BAUER, SHAWN M.; JIA, ZHAOZHONG J.; SONG, YONGHONG; XU, QING
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 023637/0058 →
Assignment of Assignor's Interest
Dec 10, 2009
From: SONG, YONGHONG; XU, QING; BAUER, SHAWN M.; JIA, ZHAOZHONG J.
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 023637/0197 →
Assignment of Assignor's Interest
Dec 29, 2009
From: JIA, ZHAOZHONG; VENKATARAMANI, CHANDRASEKAR; HUANG, WOLIN; MEHROTRA, MUKUND
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 023714/0299 →
Assignment of Assignor's Interest
Jan 13, 2010
From: LU, GENMIN; SINHA, UMA
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 023779/0904 →
Assignment of Assignor's Interest
Jun 14, 2010
From: SINHA, UMA; LU, GENMIN; CONLEY, PAMELA B.
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 024533/0407 →
Assignment of Assignor's Interest
Dec 30, 2013
From: PANDEY, ANJALI; CONLEY, PAMELA B.; SINHA, UMA; ANDRE, PATRICK
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 031860/0760 →
Release of Security Interest
Jul 2, 2020
From: HCR COLLATERAL MANAGEMENT, LLC
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 053120/0925 →
Change of Name
Dec 17, 2020
From: PORTOLA PHARMACEUTICALS, INC.
To: PORTOLA PHARMACEUTICALS, LLC
Reel/Frame 054795/0162 →
Assignment of Assignor's Interest
Dec 17, 2020
From: PORTOLA PHARMACEUTICALS, LLC
To: ALEXION PHARMACEUTICALS, INC.
Reel/Frame 054795/0630 →
Corrective Assignment to Correct the State of the Assignee Previously Recorded on Reel 054795 Frame 0162. Assignor(S) Hereby Confirms the Change of Name.
Jan 5, 2021
From: PORTOLA PHARMACEUTICALS, INC.
To: PORTOLA PHARMACEUTICALS, LLC
Reel/Frame 054899/0357 →
Assignment of Assignor's Interest
Jan 7, 2021
From: PORTOLA PHARMACEUTICALS, LLC
To: ALEXION PHARMACEUTICALS, INC.
Reel/Frame 054921/0131 →
Change of Name
Jan 7, 2021
From: PORTOLA PHARMACEUTICALS, INC.
To: PORTOLA PHARMACEUTICALS, LLC
Reel/Frame 054920/0739 →
Assignment of Assignor's Interest
Jan 7, 2021
From: ALEXION PHARMA INTERNATIONAL OPERATIONS UNLIMITED COMPANY
To: ALEXION PHARMACEUTICALS, INC.
Reel/Frame 054922/0857 →
Change of Name
Jan 12, 2021
From: PORTOLA PHARMACEUTICALS, INC.
To: PORTOLA PHARMACEUTICALS, LLC
Reel/Frame 054976/0294 →
Assignment of Assignor's Interest
Jan 12, 2021
From: PORTOLA PHARMACEUTICALS, LLC
To: ALEXION PHARMACEUTICALS, INC.
Reel/Frame 054975/0203 →
Change of Name
Jan 12, 2021
From: PORTOLA PHARMACEUTICALS, INC.
To: PORTOLA PHARMACEUTICALS, LLC
Reel/Frame 054975/0183 →
Assignment of Assignor's Interest
Jan 14, 2021
From: PORTOLA PHARMACEUTICALS, LLC
To: ALEXION PHARMACEUTICALS, INC.
Reel/Frame 054999/0218 →